Doxapram hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for doxapram hydrochloride and what is the scope of patent protection?
Doxapram hydrochloride
is the generic ingredient in two branded drugs marketed by Hikma, Chartwell Injectable, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for doxapram hydrochloride. Two suppliers are listed for this compound.
Summary for doxapram hydrochloride
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 3 |
NDAs: | 3 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 14 |
Patent Applications: | 291 |
What excipients (inactive ingredients) are in doxapram hydrochloride? | doxapram hydrochloride excipients list |
DailyMed Link: | doxapram hydrochloride at DailyMed |
Recent Clinical Trials for doxapram hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rehman Medical Institute - RMI | Phase 4 |
Erasmus Medical Center | Phase 3 |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 |
Pharmacology for doxapram hydrochloride
Drug Class | Respiratory Stimulant |
Physiological Effect | Increased Medullary Respiratory Drive |
Medical Subject Heading (MeSH) Categories for doxapram hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for doxapram hydrochloride
US Patents and Regulatory Information for doxapram hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Injectable | DOXAPRAM HYDROCHLORIDE | doxapram hydrochloride | INJECTABLE;INJECTION | 076266-001 | Jan 10, 2003 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs | DOXAPRAM HYDROCHLORIDE | doxapram hydrochloride | INJECTABLE;INJECTION | 073529-001 | Jan 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | DOPRAM | doxapram hydrochloride | INJECTABLE;INJECTION | 014879-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.